arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Definium Therapeutics, Inc.

DFTX

$46.13 ▲ +0.05 (+0.10%) at close

24 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Neutral

auto_awesome

Analytical Summary

Definium Therapeutics, Inc. demonstrates solid fundamentals with strength in Debt to Equity. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $5.0B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -14.6% ↘

FCF / Share $-0.39

Trailing P/E —

Price / Book 17.2x

FCF Yield —

Debt / Equity 0.15

info Valuation on last close. End-of-day price, Aug 7, 2026.

24-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-77.10M

↓ -230.2% —

FCF / Share Free cash flow per share

$-0.39

↓ -13.3% —

Long-Term Debt Long-term obligations

$40.77M

— +0.5% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
EPS Growth YoY (%)	-163.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-19.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-333.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-525.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	76.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	89.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-75.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2850.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	19.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-1800.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	96.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	8.2% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	63.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-230.2% Weak ↑ Weak Improving Year-over-year change in net income	-45.2% Weak ↑ Weak Improving Year-over-year change in net income	-391.6% Weak ↓ Weak Declining Year-over-year change in net income	-630.2% Weak ↓ Weak Declining Year-over-year change in net income	57.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-45.6% Weak ↓ Weak Declining Year-over-year change in net income	23.7% Good ↑ Good Improving Year-over-year change in net income	79.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-119.2% Weak ↑ Weak Improving Year-over-year change in net income	-386.7% Weak ↓ Weak Declining Year-over-year change in net income	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-71.8% Weak ↓ Weak Declining Year-over-year change in net income	-34.5% Weak ↓ Weak Declining Year-over-year change in net income	70.9% Excellent ↑ Excellent Improving Year-over-year change in net income	4.1% Caution ↓ Caution Declining Year-over-year change in net income	62.5% Excellent Excellent Year-over-year change in net income	-34.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	-13.3% Weak Weak Year-over-year change in free cash flow	—	—	—	0.3% Caution Caution Year-over-year change in free cash flow	—	—	—	0.9% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	6.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.26x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	2.62x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.70x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Return on Invested Capital (%)	-14.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-14.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-27.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-15.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-51.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-529%)	-23.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-14.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-5.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-2.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-30.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-355%)	-18.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	-27.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-19.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-13.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-212%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-10.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-26.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-7.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Debt to Equity (x)	0.15x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	0.31x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	0.22x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.10x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	—	0.09x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	0.12x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	—	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-47.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-37.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-53.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-49.48x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-34.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-52.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-50.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	-108.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	-685.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-126.32x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-269.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-655.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	-159.17x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-221.75M	$-217.26M	$20.43M	$7.80M	$-60.82M	$-273.74M	$-270.97M	$-218.88M	$-238.14M	$-99.70M	$-103.63M	$-116.89M	$-129.41M	$-142.14M	$-154.52M	$-105.74M	$-120.47M	$-133.54M	—	—	—	$-80.09M	—	—
Debt / EBITDA (x)	-0.69x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.88x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.01x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.69x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.98x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.99x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.64x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.65x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.71	$-0.50	$-0.78	$-0.50	$-0.27	$-0.42	$-0.18	$-0.08	$-1.14	$-0.59	$-0.45	$-0.76	$-0.65	$-0.02	$-0.56	$-0.04	—	$-0.59	$-0.61	$-0.11	—	—	—	—
Free Cash Flow per Share (USD)	$-0.39	—	$-0.34	$-0.35	$-0.35	—	—	—	$-0.35	—	—	—	$-0.35	—	—	—	—	—	$-0.60	$-0.03	—	—	—	—
Book Value per Share (USD)	$2.68	$3.36	$1.70	$2.45	$2.95	$3.21	$3.21	$2.80	$2.76	$1.90	$2.39	$2.73	$3.40	$3.97	$4.09	$0.29	—	$5.39	$5.86	$0.42	—	—	—	—
Tangible Book Value per Share (USD)	$2.49	$3.16	$1.44	$2.18	$2.69	$2.95	$2.97	$2.53	$2.48	$1.42	$1.90	$2.22	$2.88	$3.45	$3.56	$0.25	—	$4.68	$5.86	$0.42	—	—	—	—
Basic Weighted Avg Shares (shares)	108.79M	—	85.89M	85.35M	85.07M	—	77.91M	71.91M	47.86M	—	39.72M	38.58M	38.08M	—	29.30M	423.63M	—	—	28.01M	410.82M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Working Capital (USD)	$299.45M	$352.62M	$150.43M	$151.18M	$191.22M	$242.77M	$266.09M	$205.85M	$190.20M	$71.63M	$88.93M	$84.67M	$108.32M	$128.16M	$130.47M	$101.22M	$112.67M	$126.81M	—	—	—	$78.51M	—	—
LT Debt (USD)	$40.77M	$40.58M	$40.38M	$41.19M	$22.04M	—	$24.31M	$24.25M	$14.19M	—	$14.07M	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$278.85M	$332.33M	$130.60M	$185.40M	$222.81M	$241.45M	$262.19M	$202.05M	$196.06M	$78.13M	$95.98M	$105.97M	$130.34M	$150.92M	$153.59M	$124.50M	$136.81M	$151.66M	$164.27M	$171.63M	$180.59M	$75.87M	$4.78M	$0.00

📋 What is driving earnings? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 May 29, 2019 10-K ↗
Net Income, GAAP (USD)	$-77.10M	$-50.44M	$-67.27M	$-42.74M	$-23.35M	$-34.74M	$-13.68M	$-5.85M	$-54.40M	$-23.86M	$-17.92M	$-29.13M	$-24.82M	$-4.90M	$-16.48M	$-16.96M	$-18.45M	$-16.83M	$-17.20M	$-45.25M	$-13.76M	—	—	—
Operating Cash Flow (USD)	$-42.63M	$-42.98M	$-29.57M	$-29.60M	$-29.42M	$-25.35M	—	—	$-16.60M	$-20.56M	—	—	$-13.33M	$-12.85M	—	—	$-12.87M	$-7.83M	$-16.78M	$-11.17M	$-10.04M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 24 quarters

Definium Therapeutics, Inc.

Analytical Summary

24-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DFTX with peers